Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
98.63
-1.23 (-1.23%)
Feb 10, 2025, 7:27 PM EST - Market closed
Encompass Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 5,373 | 4,801 | 4,349 | 4,015 | 3,566 | Upgrade
|
| Revenue Growth (YoY) | 11.91% | 10.41% | 8.31% | 12.58% | -22.56% | Upgrade
|
| Cost of Revenue | 3,140 | 2,818 | 2,595 | 2,312 | 2,075 | Upgrade
|
| Gross Profit | 2,233 | 1,983 | 1,753 | 1,703 | 1,492 | Upgrade
|
| Selling, General & Admin | 266.5 | 258 | 209 | 228.5 | 213 | Upgrade
|
| Other Operating Expenses | 802.6 | 719.1 | 670.4 | 595.9 | 545.1 | Upgrade
|
| Operating Expenses | 1,369 | 1,251 | 1,123 | 1,044 | 961.1 | Upgrade
|
| Operating Income | 864.5 | 731.8 | 630.2 | 659.4 | 530.4 | Upgrade
|
| Interest Expense | -137.4 | -143.5 | -175.7 | -164.3 | -183.7 | Upgrade
|
| Earnings From Equity Investments | 3 | 3.2 | 2.9 | 3.4 | 2.9 | Upgrade
|
| Other Non Operating Income (Expenses) | 20.1 | 15.7 | -5.2 | 7.5 | 8.4 | Upgrade
|
| EBT Excluding Unusual Items | 750.2 | 607.2 | 452.2 | 506 | 358 | Upgrade
|
| Legal Settlements | - | - | - | - | -2.8 | Upgrade
|
| Other Unusual Items | -0.6 | - | -1.4 | -1 | -2.3 | Upgrade
|
| Pretax Income | 749.6 | 607.2 | 450.8 | 505 | 352.9 | Upgrade
|
| Income Tax Expense | 150.2 | 132.2 | 100.1 | 101.9 | 74.7 | Upgrade
|
| Earnings From Continuing Operations | 599.4 | 475 | 350.7 | 403.1 | 278.2 | Upgrade
|
| Earnings From Discontinued Operations | -2.8 | -12 | 13.9 | 112.3 | 90.6 | Upgrade
|
| Net Income to Company | 596.6 | 463 | 364.6 | 515.4 | 368.8 | Upgrade
|
| Minority Interest in Earnings | -140.9 | -111 | -93.6 | -103.2 | -84.6 | Upgrade
|
| Net Income | 455.7 | 352 | 271 | 412.2 | 284.2 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | 2.4 | 1.2 | 1.8 | 1 | Upgrade
|
| Net Income to Common | 455.7 | 349.6 | 269.8 | 410.4 | 283.2 | Upgrade
|
| Net Income Growth | 29.46% | 29.89% | -34.26% | 45.04% | -20.77% | Upgrade
|
| Shares Outstanding (Basic) | 100 | 100 | 99 | 99 | 99 | Upgrade
|
| Shares Outstanding (Diluted) | 102 | 101 | 100 | 100 | 100 | Upgrade
|
| Shares Change (YoY) | 0.89% | 0.90% | 0.20% | 0.40% | 0.40% | Upgrade
|
| EPS (Basic) | 4.56 | 3.51 | 2.72 | 4.15 | 2.87 | Upgrade
|
| EPS (Diluted) | 4.46 | 3.47 | 2.70 | 4.11 | 2.85 | Upgrade
|
| EPS Growth | 28.43% | 28.74% | -34.39% | 44.46% | -21.09% | Upgrade
|
| Free Cash Flow | 360.3 | 267.7 | 121.7 | 170.1 | 311.9 | Upgrade
|
| Free Cash Flow Per Share | 3.53 | 2.64 | 1.21 | 1.70 | 3.13 | Upgrade
|
| Dividend Per Share | 0.660 | 0.600 | 0.860 | 1.120 | 1.120 | Upgrade
|
| Dividend Growth | 10.00% | -30.23% | -23.21% | 0% | 1.82% | Upgrade
|
| Gross Margin | 41.56% | 41.30% | 40.32% | 42.43% | 41.82% | Upgrade
|
| Operating Margin | 16.09% | 15.24% | 14.49% | 16.42% | 14.87% | Upgrade
|
| Profit Margin | 8.48% | 7.28% | 6.20% | 10.22% | 7.94% | Upgrade
|
| Free Cash Flow Margin | 6.71% | 5.58% | 2.80% | 4.24% | 8.75% | Upgrade
|
| EBITDA | 1,164 | 1,006 | 873.8 | 879 | 733.4 | Upgrade
|
| EBITDA Margin | 21.66% | 20.95% | 20.09% | 21.89% | 20.56% | Upgrade
|
| D&A For EBITDA | 299.6 | 273.9 | 243.6 | 219.6 | 203 | Upgrade
|
| EBIT | 864.5 | 731.8 | 630.2 | 659.4 | 530.4 | Upgrade
|
| EBIT Margin | 16.09% | 15.24% | 14.49% | 16.42% | 14.87% | Upgrade
|
| Effective Tax Rate | 20.04% | 21.77% | 22.20% | 20.18% | 21.17% | Upgrade
|
| Advertising Expenses | - | 6.1 | 6.3 | 5.6 | 4.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.